LI-COR Biosciences and Aloka Co. Ltd. to Conclude Distribution

Agreement 
LINCOLN, Neb. and TOKYO, Aug. 1 /PRNewswire/ -- LI-COR Biosciences and
Aloka Co. Ltd. announce the conclusion of their distribution agreement for
LI-COR Biotechnology Products effective August 31, 2007.  This decision
reflects the strategic direction of both companies and enables Aloka to
concentrate on its own product line.  LI-COR has appointed M&S TechnoSystems
Inc. to distribute LI-COR Biotechnology Products and provide all customer
service and support in Japan effective September 1, 2007. 
"Aloka and LI-COR have had a mutually beneficial relationship since 1993,"
says Ron Stolley, LI-COR Biosciences Director of International Distribution.
"Both companies are committed to a smooth transition ensuring customer service
and support is provided at the highest standards deserved and expected by our
mutual customers.  M&S TechnoSystems personnel are already equipped, trained,
and well prepared to care for LI-COR customers." 
On January 20, 1950, Aloka was established, under the name of "Medical and
Physical Institute Co., Ltd." wholly owned by Japan Radio Co., Ltd. (JRC).
Aloka has been satisfying diverse needs and enhanced medical care requirements
by supplying medical equipment.  Aloka radiation measuring instruments are
used extensively for measurement and analysis in the fields of nuclear power
generation, medical care, biochemistry, pharmacy and others, and are playing
an important role in research and examination.  Aloka Co. Ltd. has been a
leading distributor of LI-COR sequencers and analyzers since 1993.  Aloka
introduced the LI-COR Odyssey(R) Infrared Imaging System to the Japanese
Proteomics Market in 2001. Additional information can be found at
http://www.aloka.co.jp. 
LI-COR Biosciences is a leader in the design and manufacture of instrument
systems for biotechnology and environmental research.  LI-COR pioneered the
development of infrared fluorescence labeling and detection systems for such
areas as drug discovery and DNA sequencing for genomic research.  The
company's Model 4300 system is ideally suited to the exacting demands of
functional genomics especially reverse genetics, SNP research, and AFLP(R).
The Odyssey(R) and Aerius(TM) systems offer unique infrared imaging solutions
for protein analysis of Westerns, micro plate-based assays, and molecular
imaging. 
Founded in 1971, LI-COR is a privately held company based in Lincoln,
Nebraska, U.S.A. with subsidiaries in Germany and the United Kingdom.  LI-COR
systems are used in over 100 countries and are supported by a global network
of distributors.  Further information can be obtained at http://www.licor.com. 

SOURCE  LI-COR Biosciences 
CONTACT:
D. Doc Chaves, Director of Marketing Communications, LI-COR Biosciences, +1-402-467-0750, doc.chaves@licor.com
-0- Aug/01/2007 19:30 GMT
 
 
Press spacebar to pause and continue. Press esc to stop.